SLAYEN HOWARD T

Director SLAYEN HOWARD T sold 25,000 shares of AEHR at $85.00 for $2.1M amid unprofitability and stock near 52-week high.

SLAYEN HOWARD T, a director, sold 25,000 shares (12.3% reduction) at $85.00 on 2026-04-17, reducing holdings from 203.3K to 178.3K shares. The sale occurred near the stock's 52-week high of $83.86 (current price at +0.0% from peak), following a dramatic 131.0% gain over 30 days and 191.1% over 90 days. Notably, across his entire open-market trade history (cross-ticker), this insider's prior trades show an average 90-day return of -26.8% with a 0.00% win rate, and at AEHR specifically, both prior buys (2023-10-11 and 2024-08-02) resulted in negative 90-day outcomes (-44.4% and -9.2%, respectively). The company's fundamentals present a headwind: AEHR reported quarterly revenue of $10.3M with a net loss of $3.2M, annual revenue declined 11.0% year-over-year, and the company was unprofitable over its most recent full fiscal year. The timing—a substantial reduction at near-peak valuation while the company operates at a loss—warrants investor attention, particularly given the extended rally that preceded the sale.

Director Howard T Slayen buys 20,000 shares of AEHR at $15.50; stock down 73.2% from 52-week high of $53.69.

SLAYEN HOWARD T purchased 20,000 shares at $15.50, increasing his holdings from 200.7K to 220.7K shares (+10.0%). The transaction occurs as AEHR trades 73.2% below its 52-week high and while the stock has rebounded 30.8% over the past 30 days. However, SLAYEN's cross-ticker track record shows poor timing: his prior open-market buy resulted in a 90-day return of -44.4%, with a 0% win rate across all prior buys. At AEHR specifically, his single prior buy on 2023-10-11 also delivered a negative 90-day return of -44.4%. The stock's current price of $14.39 is below the $15.50 transaction price, suggesting this latest purchase has already moved into negative territory.